SNAP-8

Acetyl Octapeptide-3 · Acetyl Glutamyl Heptapeptide-1

Skin & HairNot ApprovedPreclinicalResearchTopical

Popular for:Anti-wrinkle, topical Botox alternative, expression line reduction

0

Registered Trials

0

Trial Publications

0

PubMed References

Preclinical

Evidence Level

Overview

SNAP-8 (Acetyl Octapeptide-3) is a topical anti-aging peptide designed to mimic the mechanism of botulinum toxin (Botox) at the neuromuscular junction, but applied topically to the skin. The short version: people usually care about it for anti-wrinkle, topical botox alternative, expression line reduction, but the strength of the evidence depends heavily on indication and study type.

SNAP-8 (Acetyl Octapeptide-3) is a topical anti-aging peptide designed to mimic the mechanism of botulinum toxin (Botox) at the neuromuscular junction, but applied topically to the skin. It is an extension of the Argireline (Acetyl Hexapeptide-3) concept, with two additional amino acids for enhanced activity.

Developed by Lipotec (now part of Lubrizol), SNAP-8 competes with SNARE complex proteins to reduce the release of neurotransmitters at the neuromuscular junction. This reduces muscle contraction intensity in facial expression muscles, softening expression lines and wrinkles without injection.

Research Snapshot

What the evidence says

Preclinical

SNAP-8 currently shows 0 registered trials from ClinicalTrials.gov, 0 PubMed trial publications (0 RCT-tagged), and 0 PubMed references matching the stored source query. Treat PubMed references as literature surface area, not a count of clinical trials.

Known vs uncertain

Known signals

  • 0 registered trials are tracked from ClinicalTrials.gov intervention records.
  • 0 PubMed clinical-trial publications are indexed.
  • 0 PubMed randomized controlled trial publications are indexed.
  • 0 PubMed references are tracked separately from trial counts and can include animal, in-vitro, review, mechanism, or clinical records.

Open questions

  • Evidence strength may vary by indication, route, formulation, and population.
  • Public anecdotes can highlight interest or concern but do not establish clinical efficacy.
  • Regulatory status and compounding access can change independently from the research literature.

Mechanism of Action

SNAP-8 mimics the N-terminal end of SNAP-25 (Synaptosomal-Associated Protein 25 kDa), a component of the SNARE complex required for neurotransmitter vesicle fusion at the neuromuscular junction.

Key Research Benefits

Topical alternative to Botox for expression lines
Non-invasive — no injection required
Studied for wrinkle depth reduction (up to 63% in vitro)
Can be combined with other cosmetic peptides (GHK-Cu, etc.)
Used in many commercial anti-aging serums

Clinical Evidence Summary

Research Pipeline

Preclinical
Animal
Phase I
Phase II
Phase III
Approved

0

Registered Trials

0

Trial Publications

0

RCT Publications

0

PubMed References

ClinicalTrials.govPubMed ESearchExact-name queryChecked May 3, 2026

Registered trials are ClinicalTrials.gov intervention records. Trial publications are PubMed records tagged as clinical trials or randomized controlled trials. PubMed references are broader source-query matches and can include animal studies, in-vitro work, reviews, mechanism papers, and trial publications.

0

Registered trials

0

Trial publications

0

RCT publications

0

PubMed references

0

Reviews

0

Meta-analyses

Registered trials source

Jun 1, 2026

SNAP-8

Uses the exact compound name as a ClinicalTrials.gov intervention query.

View source

Publication counts source

May 3, 2026

SNAP-8

Uses the exact display name.

View source

Not FDA-approved as a drug. Available as a cosmetic ingredient. Widely used in commercial skincare formulations. Research compound. No prescription required for topical use.

Key PubMed References

No PubMed references matched the current source query for SNAP-8.

Check the PubMed query

Anecdotes & Sentiment

Public discussion, not clinical evidence

This section summarizes what people are talking about in public sources. It can be useful for spotting questions, hype cycles, and recurring concerns, but it is separate from the evidence sections above.

No curated public-discussion themes are live for SNAP-8 yet.

Side Effects & Safety

- Minimal systemic side effects (topical application) - Skin sensitivity or irritation possible - Effects are milder and slower than injectable Botox - Requires consistent daily application

Minimal systemic side effects (topical application)
Skin sensitivity or irritation possible
Effects are milder and slower than injectable Botox
Requires consistent daily application

Known Interactions

No curated interaction entry is live for SNAP-8 yet.

Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.

Comparison Pages

Comparison pages

All

No comparison page is linked yet.

Frequently Asked Questions

Research Disclaimer

This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Regulatory status can vary by compound, formulation, indication, and jurisdiction. Check official labeling, registry records, and qualified professional guidance before making any health-related decision. The studies referenced are linked to their original PubMed sources for verification.